Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bipin Kulkarni

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 11, 2022
Efficacy of emicizumab in von Willebrand disease (VWD) patients with and without alloantibodies to von Willebrand factor (VWF): Report of two cases and review of literatureChandrakala Shanmukhaiah, Farah Jijina, S Kannan, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|December 2, 2014
The Epidemiology of FVIII Inhibitors in Indian Haemophilia A PatientsPatricia Pinto, Tejashree Shelar, Vidhya Nawadkar, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 11, 2022
Efficacy of emicizumab in von Willebrand disease (VWD) patients with and without alloantibodies to von Willebrand factor (VWF): Report of two cases and review of literatureChandrakala Shanmukhaiah, Farah Jijina, S Kannan, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|December 2, 2014
The Epidemiology of FVIII Inhibitors in Indian Haemophilia A PatientsPatricia Pinto, Tejashree Shelar, Vidhya Nawadkar, et al.
Pageof 3